Saleability of anti-malarials in private drug shops in Muheza, Tanzania: A baseline study in an era of assumed artemisinin combination therapy (ACT)

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Ringsted, Frank M ^a   Massawe, Isolide S ^b   Lemnge, Martha M ^b   Bygbjerg, Ib C ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NATIONAL INSTITUTE OF MEDICAL RESEARCH   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ANTISPOROZOAL AGENT; ARCO; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; CO ARINATE; CO ARTESIANE; CO MALAFIN; DIHYDROARTEMISININ PLUS PIPERAQUINE; DUO COTEXCIN; METAKELFIN; NAPHTOQUINE; PYMIMETHAMINE; QUININE; SULFADOXINE; UNCLASSIFIED DRUG; ARTEMISININ DERIVATIVE; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ALLERGY; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; DISCOMFORT; DIZZINESS; DRUG COST; DRUG LEGISLATION; DRUG MARKETING; DRUG QUALITY; HEADACHE; HUMAN; HYPOTENSION; INTERVIEW; MALARIA; MONOTHERAPY; NAUSEA; PHARMACY; QUESTIONNAIRE; SKIN MANIFESTATION; TANZANIA; DRUG COMBINATION; DRUG UTILIZATION; FEMALE; METHODOLOGY; PREGNANCY; STATISTICS;

ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HUMANS; INTERVIEWS AS TOPIC; PHARMACIES; PREGNANCY; PYRIMETHAMINE; QUESTIONNAIRES; SULFADOXINE; TANZANIA;

EID: 80051592693     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-238     Document Type: Article

References (27)

1. Malaria control at the district level in Africa: the case of the Muheza district in northeastern Tanzania. Alilio MS, Kitua A, Njunwa K, Medina M, Rønn AM, Mhina J, Msuya F, Mahundi R, Depinay JM, Whyte S, Krasnik A, Bygbjerg IC, Am J Trop Med Hyg 2004 71 205 213 15331839 (Pubitemid 39121324)
2. Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Goodman C, Kachur SP, Abdulla S, Mwageni E, Nyoni J, Schellenberg JA, Trop Med Int Health 2004 9 655 663 10.1111/j.1365-3156.2004.01245.x 15189455 (Pubitemid 38833330)
3. Drug shop regulation and malaria treatment in Tanzania - why do shops break the rules, and does it matter? Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A, Health Policy Plan 2007 22 393 403 10.1093/heapol/czm033 17921151 (Pubitemid 350135555)
4. The Tanzania Food and Drugs Authority. 2010 http://www.tfda.or.tz/ addoprogramme.php
5. Ministry of Health and Social Welfare URoT, National Guidelines for Diagnosis and Treatment of Malaria Malaria control series 11 Dar es Salaam: National Malaria Control Program 2006
6. World Health Organization, WHO guidelines for the treatment of malaria Geneva: WHO/HTM/MAL/2006.1108 2006
7. Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets-a provider perspective. Alba S, Hetzel MW, Goodman C, Dillip A, Liana J, Mshinda H, Malar J 2010 9 164 10.1186/1475-2875-9-164 20550654
8. Self-medication with chloroquine in a rural district of Tanzania: a therapeutic challenge for any future malaria treatment policy change in the country. Nsimba SE, Rimoy GH, J Clin Pharm Ther 2005 30 515 519 10.1111/j.1365-2710.2005.00645.x 16336283 (Pubitemid 43960977)
9. How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy. Nsimba SE, J Ethnobiol Ethnomed 2006 2 5 10.1186/1746-4269-2-5 16403225 (Pubitemid 46979392)
10. Assessing the performance, practices and roles of drug sellers/dispensers and mothers'/guardians' behaviour for common childhood conditions in Kibaha district, Tanzania. Nsimba SE, Trop Doct 2007 37 197 201 10.1258/ 004947507782333099 17988473
11. Perception of chloroquine efficacy and alternative treatments for uncomplicated malaria in children in a holoendemic area of Tanzania: implications for the change of treatment policy. Tarimo DS, Minjas JN, Bygbjerg IC, Trop Med Int Health 2001 6 992 997 10.1046/j.1365-3156.2001.00818.x 11737836 (Pubitemid 34013515)
12. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania. Tarimo DS, Malekela DA, East Afr J Public Health 2007 4 43 46 17907761
13. Adoption of the new anti-malarial drug policy in Tanzania - a cross-sectional study in the community. Eriksen J, Nsimba SE, Minzi OM, Sanga AJ, Petzold M, Gustafsson LL, Trop Med Int Health 2005 10 1038 1046 10.1111/j.1365-3156.2005.01486.x 16185239 (Pubitemid 41445069)
14. Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. Wasunna B, Zurovac D, Goodman CA, Snow RW, Malar J 2008 7 29 10.1186/1475-2875-7-29 18252000 (Pubitemid 351389088)
15. United Republic of Tanzania, The 2002 Population and Housing Census Results Dar es Salaam, Tanzania: Government Press 2003
16. High level of resistance of Plasmodium falciparum to sulfadoxine- pyrimethamine in children in Tanzania. Rønn AM, Msangeni HA, Mhina J, Wernsdorfer WH, Bygbjerg IC, Trans R Soc Trop Med Hyg 1996 90 179 181 10.1016/S0035-9203(96)90129-7 8761583 (Pubitemid 26141091)
17. Early home-based recognition of anaemia via general danger signs, in young children, in a malaria endemic community in north-east Tan zania. Ringsted FM, Bygbjerg IC, Samuelsen H, Malar J 2006 5 111 10.1186/1475-2875-5-111 17116250 (Pubitemid 44903561)
18. World Health Organization. WHO/UNICEF Review of National Immunization Coverage-July 2009 http://apps.who.int/immunization-monitoring/en/globalsummary/ countryprofileselect.cfm
19. Community response to artemisinin-based combination therapy for childhood malaria: a case study from Dar es Salaam, Tanzania. Kamat VR, Nyato DJ, Malar J 2010 9 61 10.1186/1475-2875-9-61 20187949
20. Teule Hospital DDH Muheza. http://www.teule.or.tz/annual%20report%202007. pdf
21. High reinfection rate and treatment failures in children treated with amodiaquine for falciparum malaria in Muheza villages, Northeastern Tanzania. Lemnge MM, Alifrangis M, Kafuye MY, Segeja MD; Gesase S, Minja D, Massaga JJ, Rønn AM, Bygbjerg IC, Am J Trop Med Hyg 2006 75 188 193 16896117 (Pubitemid 46941329)
22. Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets. Alifrangis M, Lemnge MM, Rønn AM, Segeja MD, Magesa SM, Khalil IF, Bygbjerg IC, Am J Trop Med Hyg 2003 69 238 243 14628937
23. Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? Premji Z, Gbadoe AD, Marrast AC, Gaye O, Malar J 2011 10 64 10.1186/1475-2875-10-64 21410954
24. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, Fried M, Proc Natl Acad Sci USA 2009 106 9027 9032 10.1073/pnas.0901415106 19451638
25. Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene. Alifrangis M, Lusingu JP, Mmbando B, Dalgaard MB, Vestergaard LS, Ishengoma D, Am J Trop Med Hyg 2009 80 523 527 19346369
26. President' Malaria Initiative (PMI) FY Malaria Operational Plan (MOP) Tanzania. 2010 http://www.fightingmalaria.gov/countries/mops/fy10/tanzania-mop- fy10.pdf
27. Improvements in access to malaria treatment in Tanzania following community, retail sector and health facility interventions-a user perspective. Alba S, Dillip A, Hetzel MW, Mayumana I, Mshana C, Makemba A, Malar J 2010 9 163 10.1186/1475-2875-9-163 20550653